ARTICLE | Product Development
Replay launches Syena to merge NK and TCR technologies
Syena, the fourth product company to launch under Replay, is taking on TCR NK cells
February 14, 2023 10:40 PM UTC
The latest company launched under the Replay Holdings umbrella has a new take on NK cell therapies that could expand the target space to treat solid tumors.
Replay Holdings LLC and The University of Texas MD Anderson Cancer Center launched Syena to develop targeted, engineered NK cells that express a T cell receptor (TCR), rather than a CAR...